Albireo and Genpharm Announce Agreement to Commercialize Bylvay™ (odevixibat) in Saudi Arabia and the Gulf Region on August 18, 2021 "" Bylvay is approved in the U.S. and EU as only once–daily drug indicated for patients with PFIC "" "" PFIC is a life–threatening [...] Read more »